Delivery Order SPE2DB22D1202-SPE2DB25FVKA2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 31, 2025, with a ceiling value of $1,748.61 and an ultimate completion date of August 1, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,509.39 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. Performance will be executed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite...
- The Defense Logistics Agency awarded a $5,790.67 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Tobradex Eye Ointment (3.5 grams). This firm fixed-price contract, which closes on July 22, 2025, represents a single delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract is non-competitive and does not utilize a set-aside designation. Performance will occur at AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a prime contractor and pharmaceutical distribution services company, for the supply of Tobradex Eye Ointment 3.5 GM. The $11,837.44 firm fixed price contract has a performance period through March 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is providing these pharmaceutical products to support military treatment programs and...
- The Defense Logistics Agency awarded a $24,573.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Tobradex eye ointment. As the prime contractor, Amerisourcebergen will supply 3.5 gram tubes of the ointment to meet requirements under the contract. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania. The delivery order was issued on September 5, 2023 under an existing Amerisourcebergen IDIQ vehicle and runs through September 6, 2023. No...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,092.56 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4,565,330,497 units of TOBRADEX Eye Ointment 3.5GM. This delivery order contract falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a wide range of pharmaceutical and medical commodities to support military...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at three hundred thirty-one thousand sixty-two dollars to Amerisourcebergen Drug Corporation for Tobradex eye ointment. Under this contract, Amerisourcebergen will deliver 3.5 gram tubes of Tobradex ophthalmic ointment to locations in Conshohocken, Pennsylvania between August 30th and 31st, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Tobradex Eye Ointment 3.5 GM. The $3,244.52 firm-fixed-price contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical ophthalmic medication supplies to support military treatment facilities and other government healthcare programs. This award is part of a larger Indefinite Delivery Contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX Eye Ointment 3.5GM. The $3,547.88 firm fixed-price contract has an ultimate completion date of August 13, 2024. Amerisourcebergen, through its Corporate Office Division, will deliver these medical supplies to support federal healthcare providers and programs. This delivery order is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Tobradex Eye Ointment 3.5GM. The contract, valued at $1,572.17, is a Firm Fixed Price Delivery Order with a completion date of January 27, 2025. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVKA2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,434.64 to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 2, 2025, with an ultimate completion date of September 3, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Tobradex is a combination ophthalmic medication commonly used for treating eye inflammation and bacterial infections, making it a standard pharmaceutical supply item for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical and medical supply requirements for military healthcare programs worldwide, positioning it as a key supplier for the DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/2/25 |